- Home
- RANI vs KRON Comparison
RANI vs KRON Comparison
Compare RANI & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- KRON
- Stock Information
- Founded
- RANI 2012
- KRON 2017
- Country
- RANI United States
- KRON United States
- Employees
- RANI N/A
- KRON N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- KRON Medicinal Chemicals and Botanical Products
- Sector
- RANI Health Care
- KRON Health Care
- Exchange
- RANI Nasdaq
- KRON Nasdaq
- Market Cap
- RANI 55.3M
- KRON 61.5M
- IPO Year
- RANI 2021
- KRON 2020
- Fundamental
- Price
- RANI $1.23
- KRON $0.81
- Analyst Decision
- RANI Strong Buy
- KRON Buy
- Analyst Count
- RANI 6
- KRON 3
- Target Price
- RANI $11.33
- KRON $1.63
- AVG Volume (30 Days)
- RANI 145.5K
- KRON 152.2K
- Earning Date
- RANI 03-31-2025
- KRON 03-18-2025
- Dividend Yield
- RANI N/A
- KRON N/A
- EPS Growth
- RANI N/A
- KRON N/A
- EPS
- RANI N/A
- KRON N/A
- Revenue
- RANI N/A
- KRON $9,848,000.00
- Revenue This Year
- RANI N/A
- KRON N/A
- Revenue Next Year
- RANI N/A
- KRON N/A
- P/E Ratio
- RANI N/A
- KRON N/A
- Revenue Growth
- RANI N/A
- KRON 56.62
- 52 Week Low
- RANI $1.20
- KRON $0.69
- 52 Week High
- RANI $8.75
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- RANI 33.72
- KRON 25.13
- Support Level
- RANI $1.30
- KRON $0.82
- Resistance Level
- RANI $1.56
- KRON $0.89
- Average True Range (ATR)
- RANI 0.09
- KRON 0.06
- MACD
- RANI -0.03
- KRON -0.01
- Stochastic Oscillator
- RANI 8.33
- KRON 0.46
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.